Correlation Between Immix Biopharma and VTv Therapeutics
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and vTv Therapeutics, you can compare the effects of market volatilities on Immix Biopharma and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and VTv Therapeutics.
Diversification Opportunities for Immix Biopharma and VTv Therapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Immix and VTv is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and VTv Therapeutics go up and down completely randomly.
Pair Corralation between Immix Biopharma and VTv Therapeutics
Given the investment horizon of 90 days Immix Biopharma is expected to under-perform the VTv Therapeutics. In addition to that, Immix Biopharma is 1.11 times more volatile than vTv Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. vTv Therapeutics is currently generating about 0.13 per unit of volatility. If you would invest 1,357 in vTv Therapeutics on November 2, 2024 and sell it today you would earn a total of 109.00 from holding vTv Therapeutics or generate 8.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Immix Biopharma vs. vTv Therapeutics
Performance |
Timeline |
Immix Biopharma |
vTv Therapeutics |
Immix Biopharma and VTv Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immix Biopharma and VTv Therapeutics
The main advantage of trading using opposite Immix Biopharma and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
VTv Therapeutics vs. Zura Bio Limited | VTv Therapeutics vs. Phio Pharmaceuticals Corp | VTv Therapeutics vs. Immix Biopharma | VTv Therapeutics vs. NovaBay Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |